The EU is strengthening its capacity to manufacture vaccines, medicines and medical countermeasures before the next health emergency By D. Slooth, eEuropa Brussels, 16 July 2026 A new European Commission initiative signals a further shift in EU health policy: preparedness is becoming an industrial strategy involving pharmaceuticals, biotechnology, procurement and strategic manufacturing capacity. The European […]
Tag: HERA
Today’s EU pharmaceutical market is unsustainable, due to the fragmentation of EU players and public dependence on private interests. A recent Panel for the Future of Science and Technology (STOA) study of the EP proposes a solution involving the creation of a public European medicines infrastructure, a body that would control of the entire […]

